对于妇科恶性瘤的卡博普拉丁脱敏疗法的现状
Hiroshi Nishio1, Koji Matsumoto2, Hiroaki Komatsu3
1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. nishio.z3@keio.jp.
Journal of gynecologic oncology
|July 24, 2025
概括
化疗对于妇科癌症至关重要. 管理过敏反应 (HSR) 是至关重要的,特别是对于高风险患者,需要脱敏方案继续治疗.
科学领域:
- 在瘤学瘤学.
- 临床药房 临床药房
- 过敏和免疫学 过敏和免疫学
背景情况:
- 基于的化疗是治疗妇科恶性瘤的基石,无论是最初还是复发性疾病.
- 这些药物的频繁使用使得的过敏反应 (HSR) 成为瘤学家面临的重大临床挑战.
- 识别患有HSR风险增加的患者对于主动管理至关重要.
研究的目的:
- 强调在妇科癌症患者中管理过敏反应 (HSR) 的重要性.
- 确定与金HSRs发展相关的关键风险因素.
- 强调需要对患有HSRs的患者进行脱敏方案.
主要方法:
- 关于在妇科恶性瘤中使用基化疗的当前临床实践和文献的审查.
- 分析导致过敏反应的危险因素.
- 讨论消毒协议的作用和实施.
主要成果:
- 接受多种治疗线的患者,治疗间隔较长,有过敏反应史或生殖系BRCA突变的患者,面临更高的HSR风险.
- 有效的管理策略至关重要,以允许继续基于的治疗.
- 对于过敏症患者,脱敏方案是强制性的.
结论:
- 管理过敏反应是妇科瘤学护理的关键方面.
- 风险分层和主动降解敏感性协议是优化患者治疗的关键.
- 多学科团队的协作对于选择和实施适合机构环境和患者群体的适当脱敏方案至关重要.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
322
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
322
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
262
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
262
01:20Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
01:12GPCR Desensitization
6.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.5K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K